Effects of exercise on adiponectin: A systematic review

Obesity

Volumn 16, Issue 2, 2008, Pages 241-256

  Simpson, Kylie A ^a   Singh, Maria A Fiatarone ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; BLOOD; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; EXERCISE; FEMALE; HEALTH STATUS; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADIPONECTIN; ADULT; CONTROLLED CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 39449135967     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.53     Document Type: Review

References (68)

1. Pajvani UB, Du X, Combs TP et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/ adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003;278:9073-9085.
2. Delaigle AM, Jonas J-C, Bauche IB, Cornu O, Brichard SM. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004;145:5589-5597.
3. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-2556.
4. Sell H, Dietze-Schroeder D, Eckardt K, Eckel J. Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone. Biochem Biophys Res Commun 2006;343:700-706.
5. Aldhahi W, Hamdy O. Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 2003;3:293-298.
6. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-26749.
7. HottaK, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vase Biol 2000;20:1595-1599.
8. Tsao T-S, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa(Acrp30). J Biol Chem 2002;277:29359-29362.
9. Kim K-Y, Kim JK, Han SH et al. Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol 2006;176:5958-5964.
10. Ouchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-2476.
11. Salmenniemi U, Ruotsalainen E, Pihlajamaki J et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004;110:3842-3848.
12. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006;55:249-259.
13. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005;288:R1220-R1225.
14. Tsao T-S, Tomas E, Murrey HE et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 2003;278:50810-50817.
15. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949.
16. Fruebis J, TsaoTS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001;98:2005-2010.
17. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-1295.
18. Onay-Besikci A, Altarejos JY, Lopaschuk GD. gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts. J Biol Chem 2004;279:44320-44326.
19. Bluher M, Bullen JW Jr, Lee JH et al. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab 2006;91:2310-2316.
20. Chen H. Montagnani M. Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003;278:45021-45026.
21. Hattori Y, Suzuki M, Hattori S, Kasai K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003;46:1543-1549.
22. Xi W, Satoh H, Kase H, Suzuki K, Hattori Y. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem Biophys Res Commun 2005;332:200-205.
23. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-1301.
24. Matsuzawa Y. White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2005;19:637-647.
25. Arita Y, KiharaS, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
26. Hu E, Liang R Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-10703.
27. Kumada M, Kihara S, Sumitsuji S et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vase Biol 2003;23:85-89.
28. Vilarrasa N, Vendrell J, Maravall J et al. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin Endocrinol 2005;63:329-335.
29. Balagopal P, George D, Yarandi H, FunanageV, Bayne E. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab 2005;90:6192-6197.
30. Esposito K, Pontillo A, Di Palo C et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-1804.
31. Faraj M, Havel PJ, Phelis S et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003;88:1594-1602.
32. Oberbach A, Tonjes A, Kloting N et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006;154:577-585.
33. Manigrasso MR, Ferroni P, Santilli F et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005;90:5876-5879.
34. Hulver MW, Zheng D, Tanner CJ et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 2002;283:E861-E865.
35. Fatouros IG, Tournis S, Leontsini D et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab 2005;90:5970-5977.
36. Giannopoulou I, Fernhall B, Carhart R et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 2005;54:866-875.
37. Bruun JM, Helge JW, Richelsen B, Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 2006;290:E961-E967.
38. Herbert RD. Confidence Interval Calculator Version 4.1. (Updated 26/01/04) 〈http://www.pedro.fhs.usyd.edu.au/tutorial.html〉 (2004). Accessed 24 August 2006.
39. Becker LA. Effect Size Calculators. (Revised 20/03/00) 〈http://web.uccs.edu/lbecker/Psy590/escalc3.htm〉 (1999). Accessed 25 September 2006.
40. Middel B, van Sonderen E. Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research .Int J Integr Care 2002;2:1-22.
41. Diabetes Trials Unit. HOMA Calculator Version 2.2. (Updated 30/06/04) 〈http://www.dtu.ox.ac.uk./index.php?maindoc=/homa/index.php〉 (2004). Accessed 19 November 2006.
42. Verhagen AR de Vet HC, de Bie RA et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235-1241.
43. Trosild M, Lappegard KT, Mollnes TE, Arnesen H, Seljeflot I. Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome. Scand J Clin Lab Invest 2005;65:283-290.
44. Ryan AS, Nicklas BJ, Berman DM, Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 2003;27:1066-1071.
45. Ferguson MA, White LJ, McCoy S et al. Plasma adiponectin response to acute exercise in healthy subjects. Eur J Appl Physiol 2004;91:324-329.
46. Hara T, Fujiwara H, Nakao H et al. Body composition is related to increase in plasma adiponectin levels rather than training in young obese men. Eur J Appl Physiol 2005;94:520-526.
47. Conus F, Allison DB, Rabasa-Lhoret R et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004;89:5013-5020.
48. Yokoyama H, Hirose H, Ohgo H, Saito I. Associations among lifestyle status, serum adiponectin level and insulin resistance. Intern Med 2004;43:453-457.
49. Tsukinoki R, Morimoto K, Nakayama K. Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis 2005;4:27.
50. St-Pierre DH, Faraj M, Karelis AD et al. Lifestyle behaviours and components of energy balance as independent predictors of ghrelin and adiponectin in young non-obese women. Oabetes Metab 2006;32:131-139.
51. Kondo T, Kobayashi I, Murakami M. Effect of exercise on circulating adipokine levels in obese young women. Endocr J 2006;53:189-195.
52. Nassis GP, Papantakou K, Skenderi K et al. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism 2005;54:1472-1479.
53. Polak J, Klimcakova E, Mora C et al. Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women. Metabolism 2006;55:1375-1381.
54. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P, Gautier JF. Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 2003;149:421-424.
55. Jamurtas AZ, Theocharis V, Koukoulis G et al. The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur J Appl Physiol 2006;97:122-126.
56. Jurimae J, Purge P, JurimaeT. Adiponectin is altered after maximal exercise in highly trained male rowers. Eur J Appl Physiol 2005;93:502-505.
57. Jurimae J, Purge P, Jurimae T. Adiponectin and stress hormone responses to maximal sculling after volume-extended training season in elite rowers. Metabolism 2006;55:13-19.
58. Jurimae J, Purge P, JurimaeT, von Duvillard SP. Bone metabolism in elite male rowers: adaptation to volume-extended training. Eur J Appl Physiol 2006;97:127-132.
59. Kraemer RR, Aboudehen KS, Carruth AK et al. Adiponectin responses to continuous and progressively intense intermittent exercise. Med Sci Sports Exerc 2003;35:1320-1325.
60. Punyadeera C, Zorenc AHG, Koopman R et al. The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Eur J Endocrinol 2005;152:427-436.
61. Yatagai T, Nishida Y, Nagasaka S et al. Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. EndocrJ 2003;50:233-238.
62. Brekke HK, Lenner RA, Taskinen M-R et al. Lifestyle modification improves risk factors in type 2 diabetes relatives. Diabetes Res Clin Pract 2005;68:18-28.
63. Hsieh CJ, Wang PW. Effectiveness of weight loss in the elderly with type 2 diabetes mellitus. J Endocrinol Invest 2005;28:973-977.
64. Marcell TJ, McAuley KA.Traustadottir T, Reaven PD. Exercise training is not associated with improved levels of C-reactive protein or adiponectin. Metabolism 2005;54:533-541.
65. O'Leary VB, Marchetti CM, Krishnan RK et al. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol 2006;100:1584-1589.
66. Yokoyama H, Emoto M, Araki T et al. Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes. Diabetes Care 2004;27:1756-1758.
67. Taylor HL, Jacobs DR Jr, Schucker B et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978;31:741-755.
68. Belloc NB, Breslow L. Relationship of physical health status and health practices. Prev Med 1972;1:409-421.